28. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber

Abstracts (HTML) List of Authors

Abdulkarim, M

Atypische Präsentation der Primär biliären Zirrhose bei Männern

Abdullah, Z

Hepatic fibrosis attenuates virus-specific CD8 T cell immunity causing virus persistence
Hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism

Ackermann, K

Klonierung AFP-spezifischer HLA.A2 allo-restringierter cytotoxischer T-Zellen aus dem naiven T Zell Repertoire

Adrian, I

Evidence for differential modulation of liver fibrogenesis by selective inhibition of the chemokine receptor CCR1 in a toxic model but not Abcb4-/- mice

Ahearn, AJ

Functional analysis of immunological mechanisms following mouse liver transplantation

Ahmad, G

Lactoferrin gene expression upregulation in liver during turpentine oil- or bacterial LPS-induced acute phase reaction

Ahmad, S

Changes of LCN–2 gene expression in different organs in a rat model of tissue damage

Ahrenstorf, G

Chronic hepatitis E in patients with CVID in Germany?

Alberts, R

Identification of phenotypic and expression quantitative trait loci (p/eQTLs) affecting liver fibrosis by genome-wide association analysis in recombinant inbred mouse lines

Albrecht, U

Dynamic model of IL–6 and IL–1beta dependent signalling in primary murine hepatocytes

Al-Debi, A

Intestinal inflammation induces alterations in enterohepatic Fgf15 signalling, changes in hepatic bile acid metabolism and a “toxic bile” composition in DSS-treated mice

Aleithe, S

The role of Suppressor of Fused in the regulation of Hedgehog and Wnt/ß-Catenin signaling pathway in adult liver

Alexandrov, A

THE ENTRY INHIBITOR MYRCLUDEX-B EFFICIENTLY BLOCKS VIRAL SPREADING IN VIVO IN HUMAN LIVER CHIMERIC uPA/ SCID MICE PREVIOUSLY INFECTED WITH HEPATITIS B VIRUS

Alinger, B

Expression pattern of stem cell markers in a tissue microarray of human biliary tract cancer

Allgayer, S

Add-on of pegylated interferon alpha–2a (PEG-IFN) triggers antigen-independent TNF-alpha production by CD4+ T cells in patients with pretreated chronic hepatitis B

Allweiss, L

TREATMENT WITH PEGYLATED INTERFERON-ALPHA INDUCES SUSTAINED SUPPRESSION OF BOTH VIRUS REPLICATION AND ANTIGENEMIA IN HUMANIZED uPA/SCID MICE STABLY INFECTED WITH HBV
PRETREATMENT OF HUMANIZED uPA/SCID MICE WITH INTERFERON ALPHA STRONGLY INHIBITS THE ESTABLISHMENT OF HBV INFECTION
THE ENTRY INHIBITOR MYRCLUDEX-B EFFICIENTLY BLOCKS VIRAL SPREADING IN VIVO IN HUMAN LIVER CHIMERIC uPA/ SCID MICE PREVIOUSLY INFECTED WITH HEPATITIS B VIRUS
HDV LACKING HBV CAN INFECT HUMAN HEPATOCYTES IN THE LIVER OF CHIMERIC uPA/SCID MICE AND PERSIST FOR AT LEAST SIX WEEKS BEFORE BEING RESCUED BY SUPERINFECTION WITH HBV

Al-Malat, T

Bariatric surgery ameliorates NAFLD in morbidly obese patients

Al Massoudi, M

JNK1 is protective for the progression of NEMO-dependent hepatitis

Al-Saeedi, M

Analysis of the cytokine response in a mouse model of liver ischemia / reperfusion injury

Al-samman, M

G-Protein-Rezeptor abhängige Immunmodulation durch Induktion der KC Expression (murines CXCL8/IL–8 Homolog) in murinen hepatischen Sternzellen nach Stimulation mit CXCL9

Alshuth, U

The Role of Weight Loss (WL) as On-Tretament Predictive Factor for SVR in the Treatment of Chronic Hepatitis C (CHC) Patients with Peginterferon alfa–2A (PEG) and Ribavirin (RBV)
Comparison of therapy outcome of patients with drug addiction (DA) versus patients with former iv drug use (IVDU) treated with Peginterferon alfa–2a/Ribavirin in real life setting
Confirmation of high SVR rates after shortening duration of treatment with Peginterferon alfa–2a (PEG) and Ribavirin (RBV) in Chronic Hepatitis C (CHC) Patients with RVR in Real Life

Altinbas, A

Bariatric surgery ameliorates NAFLD in morbidly obese patients

Altmüller, J

Identifizierung von neuen microRNA-Zieldomänen während der myofibroblastischen Transdifferenzierung von hepatischen Sternzellen durch "Next Generation Sequencing"

Amanzada, A

Persistent HCV-infection and liver damage change vitamin-D-metabolism
IL28B allelic variation but not polymorphism of CYP27B1 or genotype of HCV is associated with spontaneous elimination of HCV-infection
IL28B genetic variation and ratio of y-GT/ALT as predictors for virological response in chronic hepatitis C virus genotype 1 infected patients
PECAM–1 (CD31)-gene expression is downregulated by TNF-α or Interferon (IFN-) but upregulated by TGF–1 in peripheral blood leukocytes

Amarapurkar, D

Telbivudine treatment improves renal function of Chronic Hepatitis B (CHB) patients

Amer, W

TGF-beta mediates transcriptional repression of miR–29 a/b1 during liver fibrosis

Andersen, JB

Mechanistic and therapeutic implications of PDGF-b activation during liver fibrogenesis

Andersson, TB

Characteristics of human non-cirrhotic and cirrhotic liver sections in a novel ex vivo perfusion system

Angel, P

RAGE is required for oval cell activation and inflammation-associated mouse liver carcinogenesis

Armbruster, J

Die Ko-Aktivierung von AKT and N-Ras in der Mäuseleber führt zu einer raschen Hepatokarzinogenese, vermittelt über mTORC1, FOXM1/SKP2 und c-Myc

Armeanu-Ebinger, S

Novel oncolytic Sendai viruses (SeV) for the virotherapeutic treatment of HCC

Arndt, S

Ribavirin beeinflusst unterschiedlich die Funktionen von CD4+ TH1-, TH2- und regulatoischen T-Zell-Klonen bei chronischer Hepatitis C
BMP6 protects against hepatic inflammation and fibrosis in experimental NASH models

Arnold, N

Genetic characteristics of the human hepatic stellate cell line LX–2

Arrese, M

Cultivation of primary hepatocytes induces an inflammation-cholestasis response that resembles features of in vivo inflammation during damage and regeneration

Aselmann, H

Patienten mit HCC profitieren von Extended Criteria Donor Organs

Atreya, I

Antigen cross-presentation in the liver generates protective memory CD8+ T cells in the absence of inflammation

Ayata, K

P2Y2 receptor function aggravates acute hepatitis by regulating neutrophil infiltration and hepatocyte survival